Sex: F
Vaccine: PPV
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Injection site pain, Malaise, Muscular weakness
Clinical narrative: The Patient had two previous doses in unspecified date in 2007 or 2008 and on an unspecified date in 2013 or 2014 with only minor pain and low grade fever.; The Patient had two previous doses in unspecified date in 2007 or 2008 and on an unspecified date in 2013 or 2014 with only minor pain and low grade fever.; she could not lift her left arm / the left arm felt weak / "no strength in that arm"; around 2 pm developed increasing pain; fever of 100 °F; general malaise; "She had a reaction to the PNEUMOVAX 23 shot"; she could not lift her left arm / the left arm felt weak / "no strength in that arm"; pain with lifting her arm-needed to use the right arm to hold the left arm / The pain is reported as extreme.; finger numbness; This spontaneous report was received from a 56-year-old female patient referring to herself.  The patient's concurrent conditions included asthma, drug hypersensitivity and food allergy. The patient's medical history included herpes zoster. Previous drug reactions/allergies included allergy to ibuprofen, soy and peanuts. Concomitant therapies included fluticasone furoate (+) vilanterol trifenatate (BREO), beclomethasone dipropionate (QNASL), olopatadine hydrochloride (PATANASE), albuterol sulfate (PROAIR) and vitamins (unspecified).  On unspecified dates in 2007 (reported as 2007 or 2008) and in 2013 (reported as 2013 or 2014), the patient was vaccinated with the first and second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), respectively; (strength, dose, frequency, lot # and expiration date were not reported) intramuscularly. On unspecified dates after those vaccinations, she experienced minor pain and low-grade fever. On 18-SEP-2019 in the morning, the patient was vaccinated with a third dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, dose, frequency, lot # and expiration date were not reported) in the left arm, intramuscularly, for prophylaxis (indication reported as asthma).  On the same date, the patient went to work and around 14:00, she developed a reaction to the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) shot (vaccination complication), which included increasing pain (injection site pain) and finger numbness in the left hand (hypoaesthesia). She left work early and while changing, she found that she could not lift her left arm, her arm felt weak and without strength (injected limb mobility decreased and muscular weakness). Then, she contacted the physician and spoke with the Nurse Manager, who sent her to the minor emergency clinic. At the emergency clinic, she reported fever of 100 Farenheit degrees (F) (pyrexia), extreme pain with lifting her arm (she needed to use the right arm to hold the left arm) (pain in extremity) and general malaise (malaise). As treatment for the events, she was placed on acetaminophen (TYLENOL) and ice. It was reported that there were no flair-up of asthma symptoms, the patient was not hospitalized and there were no laboratories/studies performed yet. The outcome for the events of minor pain and low-grade fever was not reported. At the reporting time, the patient was not recovered from vaccination complication, injection site pain, hypoaesthesia, injected limb mobility decreased, muscular weakness, pyrexia (onset date: 18-SEP-2019), pain in extremity and malaise.   Relatedness between all the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.